Skip to content

Exagen Inc. XGN Free cash flow margin

Free cash flow margin at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
9.8%+1.0pp
Quest Diagnostics logo
Quest DiagnosticsDGX
11.8%+1.4pp
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-11,123.8%-13,374pp
CareDx logo
CareDxCDNA
-0%0.0pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
13.8%-0.2pp
Revvity logo
RevvityRVTY
17%-1.9pp

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Calculated from Exagen Inc.’s reported figures.

Based on trailing twelve months.

The official record: Exagen Inc.’s 10-Q, filed July 29, 2025, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s free cash flow margin?
Exagen Inc. (XGN) reported free cash flow margin of -27.5% in Q2 2025.
What is the long-term trend for Exagen Inc.'s free cash flow margin?
Over 3 years (2020 to 2024), Exagen Inc.'s free cash flow margin has grown at a -10.1% compound annual growth rate (CAGR), from -34.6% to -25.2%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.